Select Publications
Conference Abstracts
2018, 'Activity and Capacity Profile of Transplant Physicians and Centres in Australia and New Zealand', in BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, ELSEVIER SCIENCE INC, UT, Salt Lake City, Vol. 24, pp. S272 - S273, presented at Blood and Marrow Transplantion Tandem Meetings of the Center-for-International-Blood-and-Marrow-Transplant-Research (CIBMTR) / American-Society-for-Blood-and-Marrow-Transplantation (ASBMT), UT, Salt Lake City, 21 February 2018 - 25 February 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000425476000382&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Long-term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non-Hodgkin lymphoma', in British Journal of Haematology, Vol. 178, pp. 250 - 256, http://dx.doi.org/10.1111/bjh.14667
,2016, 'Graft Transit Time has no Effect on Outcome in Unrelated Donor Myeloablative Haematopoietic Cell Transplants (HCT) Performed in Australia and New Zealand: An Australasian Bone Marrow Transplant Recipient Registry (ABMTRR) Study', in BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, ELSEVIER SCIENCE INC, HI, Honolulu, Vol. 22, pp. S345 - S346, presented at BMT Tandem Meetings, HI, Honolulu, 18 February 2016 - 22 February 2016, http://dx.doi.org/10.1016/j.bbmt.2015.11.836
,2007, 'Pneumonitis and renal toxicity with sirolimus based GVHD prophylaxis for RIC allogeneic', in Haematologica - the Hematology Journal, Ferrata Storti Foundation, Vol. 92, pp. 516 - 516
,